Separated Animal Oil Or Solidified Form Thereof Derived From Animal Flesh And Other Than From Liver Or Dairy Type Patents (Class 424/522)
  • Patent number: 10456412
    Abstract: The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: October 29, 2019
    Assignee: Aker BioMarine Antarctic AS
    Inventors: Asgeir Saebo, Finn Myhren, Nils Hoem
  • Patent number: 10189770
    Abstract: The present invention provides a method of producing/purifying highly unsaturated fatty acids and/or derivatives thereof while suppressing deterioration of a silver salt aqueous solution, in production/purification of highly unsaturated fatty acids and/or derivatives thereof using the aqueous solution of silver salt. The present invention also contacts or mixes a mixture having a peroxide value (POV) of 10 or smaller with an aqueous solution of silver salt, in a method of purifying highly unsaturated fatty acids and/or derivatives thereof from a mixture comprising highly unsaturated fatty acids and/or derivatives thereof.
    Type: Grant
    Filed: May 30, 2016
    Date of Patent: January 29, 2019
    Assignee: Bizen Chemical Co., Ltd.
    Inventors: Mitsumasa Mankura, Yoshihisa Misawa, Yoshio Shimizu
  • Patent number: 10154978
    Abstract: Some aspects of the invention provide for a method of treating hepatic disorders, lipidemias and cardiac-related risk factors using polyunsaturated fatty acids which are modified in certain positions to attenuate oxidative damage by Reactive Oxygen Species (ROS) and/or suppress the rate of formation of reactive products and toxic compounds.
    Type: Grant
    Filed: April 24, 2012
    Date of Patent: December 18, 2018
    Assignee: Retrotope, Inc.
    Inventor: Mikhail S. Shchepinov
  • Patent number: 10105376
    Abstract: The present invention relates to compositions comprising omega-3 fatty acid derivatives, and in particular to compositions comprising omega-3 phospholipids in combination with other omega-3 derivatives.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: October 23, 2018
    Assignee: AKER BIOMARINE ANTARCTIC AS
    Inventors: Nils Hoem, Lena Burri, Kjetil Berge
  • Patent number: 10092573
    Abstract: In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea. In alternative embodiments, the invention provides pharmaceuticals and products (articles) of manufacture for delivering these compositions and formulations to an individual, e.g., a human or an animal.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: October 9, 2018
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Thomas Julius Borody, Sanjay Ramrakha, John Saxon, Antony Wettstein
  • Patent number: 10058116
    Abstract: A product for infant formula with improved nutritional value and digestive properties than currently available infant formulas, which is comprised of at least one of either powdered goat milk or pasteurized liquid goat milk; the powdered or liquid goat milk is diluted with water; a probiotic; a carbohydrate; Omega 3 vitamins; a mono-saturated fat; a natural source of iron, folic acid, B vitamins, and vitamin E; and, a natural source of lauric acid.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: August 28, 2018
    Inventor: Cari Genea Crossley
  • Patent number: 10004247
    Abstract: Disclosed are human milk fat (HMF) substitutes, processes for preparation thereof, uses thereof, and fat blends and formula containing the HMF substitutes. A fat base composition of the invention includes a mixture of vegetable-derived triglycerides, with less than 50% of the fatty acid residues bonded at the sn-2 position being saturated; and/or with the amount of saturated fatty acid residues bonded at the sn-2 position of the glycerol backbone less than about 43.5% of the total amount of the fatty acid residues. Typically, substantially all of the saturated fatty acids bonded at the sn-2 position of the glycerol backbone are palmitic acid residues. Also disclosed are substitute HMF compositions including a blend of at least 25% or at least 30% of the fat base composition of the invention with up to 75%, or respectively up to 70%, of at least one vegetable oil. Processes for preparing the fat base compositions and blend are also disclosed.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: June 26, 2018
    Assignee: ENZYMOTEC LTD.
    Inventors: Avidor Shulman, Gai Ben Dror, Hala Laouz, Dov Yaakobi, Zohar Bar-On, Gregory Blinder, Iris Meiri-Bendek, Yael Herzog
  • Patent number: 9969954
    Abstract: The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: May 15, 2018
    Assignees: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, GRAINS RESEARCH AND DEVELOPMENT CORPORATION, NUSEED PTY LTD
    Inventors: James Robertson Petrie, Surinder Pal Singh, Robert Charles de Feyter
  • Patent number: 9932290
    Abstract: The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: April 3, 2018
    Assignees: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, GRAINS RESEARCH AND DEVELOPMENT CORPORATION, NUSEED PTY LTD
    Inventors: James Robertson Petrie, Surinder Pal Singh, Robert Charles de Feyter
  • Patent number: 9932541
    Abstract: The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: April 3, 2018
    Assignees: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, GRAINS RESEARCH AND DEVELOPMENT CORPORATION, NUSEED PTY LTD
    Inventors: James Robertson Petrie, Surinder Pal Singh, Robert Charles de Feyter
  • Patent number: 9884041
    Abstract: Provided is a composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient. The composition of the present invention can be used to advantage as a drug or functional food composition which not only exhibits activity in the prevention or treatment of obesity, hyperlipidaemia or fatty liver but which also causes a significant reduction in fasted blood sugar and blood insulin concentration and hence has an effect in improving Type-2 diabetes or insulin resistance and also improves metabolic disorder which is closely associated therewith.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: February 6, 2018
    Assignee: YONSEI UNIVERSITY TECHNOLOGY HOLDINGS, INC.
    Inventor: Tae Sun Park
  • Patent number: 9877944
    Abstract: Disclosed is a composition including a fish oil and a juice in an oil-in-water emulsion for use in treatment and post-treatment of cancer.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: January 30, 2018
    Assignee: Smartfish AS
    Inventor: Janne Sande Mathisen
  • Patent number: 9730966
    Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. Further, a method of reducing appetite in humans by administering a krill oil composition is also disclosed.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: August 15, 2017
    Assignee: AKER BIOMARINE ANTARTIC AS
    Inventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Sebastiano Banni, Daniele Mancinelli, Nils Hoem, Hogne Vik
  • Patent number: 9675562
    Abstract: The present disclosure is drawn to an adhesive peel-forming formulation for dermal delivery of a drug, comprising a drug, a solvent vehicle, and a polymer peel-forming agent. The solvent vehicle can comprise a volatile solvent system comprising one or more volatile solvent, and a non-volatile solvent system comprising two or more non-volatile solvents. The non-volatile solvent system can have a solubility with respect to the drug that is within a window of operable solubility such that the drug is deliverable at therapeutically effective rates over a sustained period of time.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: June 13, 2017
    Assignee: Crescita Therapeutics Inc.
    Inventors: Jie Zhang, Kevin S. Warner, Michael A. Ashburn, Larry D. Rigby, Suyi Niu
  • Patent number: 9463211
    Abstract: The subject patent discloses a method for treating intertrigo on the underside of a female breasts which comprises (1) applying a skin salve to the underside of the female breasts, wherein the female breasts are dry, and wherein the skin salve is comprised of (i) petrolatum, (ii) from 11 weight percent to 60 weight percent beeswax, and (iii) from 0.25 weight percent to 10 weight percent peppermint oil, wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s, and (2) allowing the skin salve to remain in contact with female breasts for a period of at least 4 hours.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: October 11, 2016
    Inventor: Teresa D. Carter
  • Patent number: 9375453
    Abstract: New krill oil compositions are disclosed as having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obatined are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: June 28, 2016
    Assignee: AKER BIOMARINE ANTARCTIC AS
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Patent number: 9333242
    Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.
    Type: Grant
    Filed: January 22, 2013
    Date of Patent: May 10, 2016
    Assignee: Hybrid Medical, LLC
    Inventors: Jeff Twidwell, Joel Buckley, Harold Hoium
  • Patent number: 9150815
    Abstract: Organic solvent-free processes for obtaining krill oil compositions are disclosed. The processes include a) cooking krill in a cooker vessel for a time and temperature sufficient to denature the protein content of the krill and cause a first solid krill fraction and first liquid krill fraction to be formed while substantially avoiding emulsification of the first solid and first liquid krill fractions; b) removing the first solid and first liquid krill fractions from the cooker vessel at a temperature of at least about 90° C.; c) separating the first solid fraction and the first liquid fraction; and d) obtaining krill oil with neutral enriched from the first liquid fraction, and e) by pressing of first solid fraction to obtain press liquid or a second liquid krill fraction for obtaining krill oil with phospholipids enriched krill oil, the separating and the obtaining steps being carried out without the use of organic solvents.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: October 6, 2015
    Assignees: Tharos Ltd., Lonza Ltd.
    Inventors: Dimitri Sclabos Katevas, Raúl R. Toro Guerra, Mario M. Chiong Lay
  • Patent number: 9138446
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: September 22, 2015
    Inventors: Scott Alan Weisenfluh, Ketan Desai, Sandra Kroposky
  • Patent number: 9119864
    Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: September 1, 2015
    Assignee: AKER BIOMARINE ANTARCTIC AS
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Patent number: 9084433
    Abstract: The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: July 21, 2015
    Assignee: N. V. Nutricia
    Inventors: Eric Alexander Franciscus Van Tol, Linette Eustachia Maria Willemsen, Marleen Antoinette Koetsier, Christopher Beermann, Bernd Stahl
  • Patent number: 9078905
    Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: July 14, 2015
    Assignee: AKER BIOMARINE ANTARCTIC AS
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Patent number: 9068142
    Abstract: The present invention contemplates the creation of a low fluoride oil processed from a phospholipid-protein complex (PPC) formed immediately upon a crustacean (i.e., for example, krill) catch. The process comprises disintegrating the crustaceans into smaller particles, adding water, heating the result, adding enzyme(s) to hydrolyze the disintegrated material, deactivating the enzyme(s), removing solids from the enzymatically processed material to reduce fluoride content of the material, separating and drying the PPC material. Then, using extraction with supercritical CO2 and ethanol as solvents, inter alia krill oil is separated from the PPC. In the extraction the krill oil can be separated almost wholly from the feed material. The products have low fluoride content. The manufacturing costs in the extraction process are relatively low.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: June 30, 2015
    Assignee: OLYMPIC SEAFOOD AS
    Inventors: Inge Bruheim, Mikko Griinari, Stig Rune Remoy
  • Publication number: 20150132280
    Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 14, 2015
    Applicant: ORTHO-NUTRA, LLC
    Inventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
  • Publication number: 20150104503
    Abstract: A complex is provided, including a phospholipid and curcumin, wherein the phospholipid is sourced from a marine oil.
    Type: Application
    Filed: May 22, 2013
    Publication date: April 16, 2015
    Inventor: Harold Gordon CAVE
  • Publication number: 20150093445
    Abstract: Topically administrable compositions and methods for treating skin conditions in mammals, such as acne, rosacea, keratosis pilaris, photo-aging, and photo-rejuvenation. The composition includes a therapeutic amount of antihistamine selected from the group consisting of a non-sedating antihistamine, a physiologically acceptable acid of a non-sedating antihistamine, a salt of a non-sedating antihistamine, an amide of a non-sedating antihistamine, and a combination of two or more of these, and emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination of these. The composition further includes a therapeutic amount of topical retinoid. The combination of non-sedating antihistamine and retinoid with emu oil has been found to produce a synergistic effect that is more effective in the treatment of skin conditions than the compound used separately.
    Type: Application
    Filed: March 17, 2013
    Publication date: April 2, 2015
    Inventor: Alexander Zemtsov
  • Publication number: 20150086644
    Abstract: Topically administrable compositions and methods are included for treating inflammatory skin disease in mammals. The composition includes a therapeutic amount of antihistamine selected from the group consisting of a non-sedating antihistamine, a physiologically acceptable acid of a non-sedating antihistamine, a salt of a non-sedating antihistamine, an amide of a non-sedating antihistamine, and a combination of two or more of these, and emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination of these. The composition further includes a therapeutic amount of topical corticosteroid. The combination of non-sedating antihistamine and corticosteroid with emu oil has been found to produce a synergistic effect that is more effective in the treatment of inflammatory skin disease than the compounds used separately.
    Type: Application
    Filed: March 17, 2013
    Publication date: March 26, 2015
    Inventor: Alexander Zemtsov
  • Patent number: 8932641
    Abstract: The present invention provides a dried amnion which is dried with maintaining tissues of a raw amnion and can be easily stored for a prolonged period of time. An amnion which is dried with maintaining cells and tissues of a raw amnion can be produced by repeating a pressure-reducing operation and a pressure-recovery operation several times, the pressure-reducing operation comprising continuously heating a raw amnion placed in a treatment vessel by a far-infrared heater provided in the treatment vessel and reducing the pressure of the inside of the treatment vessel, and the pressure-recovery operation comprising recovering the reduced pressure of the inside of the treatment vessel with heating the amnion by microwaves irradiated from a microwave heating apparatus provided outside of the treatment vessel, and the amnion is characterized by retaining basement membranes and connective tissues which are constituents of the raw amnion.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: January 13, 2015
    Assignee: Amnos Co., Ltd.
    Inventors: Toshio Nikaido, Toshiko Yoshida, Motonori Okabe, Ayaka Toda, Kiyotaka Kitagawa, Masahiko Arakawa
  • Publication number: 20150010615
    Abstract: The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.
    Type: Application
    Filed: January 11, 2013
    Publication date: January 8, 2015
    Applicants: DHARMA BIOMEDICAL, LLC, FLAVEX NATUREXTRAKTE GMBH
    Inventors: Steven J. Melnick, Karl-Werner Quirin, Cheppail Ramachandran, Melvin Rothberg
  • Publication number: 20150004223
    Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Publication number: 20150004227
    Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
  • Patent number: 8916207
    Abstract: A corneal cover or corneal implant to be placed within or onto the surface of the cornea is made of bony fish scales and a contact lens is made of bony fish scales.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: December 23, 2014
    Assignee: Body Organ Biomedical Corp.
    Inventors: Chien-Cheng Lin, Horng-Ji Lai, Shang-Ming Lin, Feng-Huei Lin
  • Publication number: 20140370115
    Abstract: The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.
    Type: Application
    Filed: June 13, 2014
    Publication date: December 18, 2014
    Inventors: Nils Hoem, Asgeir Saebo
  • Publication number: 20140363517
    Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.
    Type: Application
    Filed: April 3, 2014
    Publication date: December 11, 2014
    Applicant: AKER BIOMARINE AS
    Inventors: Inge BRUHEIM, Snorre TILSETH, Jeffery COHN, Mikko GRIINARI, Sebastiano BANNI, Daniele MANCINELLI, Nils HOEM, Hogne VIK
  • Patent number: 8906428
    Abstract: The mineral composition is prepared by mixing 100 parts by weight of deep sea water, dead sea water, underground salt water, sea water, aboveground salt water, mineral water, drinking water, fresh water, underground water or water with salt dissolved therein, 1-15 parts by weight of sea weed, 0.1-10 parts of weight of a vegetable oil, 0.1-10 parts by weight of an animal oil, 0.1-10 parts by weight of a soap or saponificated product of a vegetable oil, 0.1-10 parts by weight of a soap or saponificated product of an animal oil, 0.1-5 parts by weight of glycerin, 0.1-5 parts by weight of an alcohol, 0.1-5 parts by weight of baking powder, and 0.1-10 parts by weight of one or more acids of glacial acetic acid, phytic acid, malic acid, erythorbic acid, tartaric acid, citric acid, succinic acid and L-aspartic acid.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: December 9, 2014
    Inventor: Dae Eun Yang
  • Publication number: 20140356447
    Abstract: Organic solvent-free processes for obtaining krill oil compositions are disclosed. The processes include a) cooking krill in a cooker vessel for a time and temperature sufficient to denature the protein content of the krill and cause a first solid krill fraction and first liquid krill fraction to be formed while substantially avoiding emulsification of the first solid and first liquid krill fractions; b) removing the first solid and first liquid krill fractions from the cooker vessel at a temperature of at least about 90° C.; c) separating the first solid fraction and the first liquid fraction; and d) obtaining krill oil with neutral enriched from the first liquid fraction, and e) by pressing of first solid fraction to obtain press liquid or a second liquid krill fraction for obtaining krill oil with phospholipids enriched krill oil, the separating and the obtaining steps being carried out without the use of organic solvents.
    Type: Application
    Filed: June 20, 2014
    Publication date: December 4, 2014
    Inventors: Dimitri SCLABOS KATEVAS, Raúl R. TORO GUERRA, Mario M. CHIONG LAY
  • Publication number: 20140352630
    Abstract: The present invention provides compositions and methods for the control and management of wildlife populations (including domesticated animals) and pests such as rodents, birds including geese, deer and other herbivores such as rabbits, ground hogs, raccoons, moose and elk, tunneling animals such as moles, voles and gophers and insects, carnivores and other organisms such as predators. Specifically provided are FIFRA exemption-based formulations which may be applied to natural or artificial surfaces.
    Type: Application
    Filed: October 25, 2012
    Publication date: December 4, 2014
    Inventor: James J. MESSINA
  • Patent number: 8895074
    Abstract: A method of parenterally administering a composition, the method including parenterally administering to a person a composition including krill oil in an oil-in-water emulsion. A parenterally applicable pharmaceutical composition, including an oil-in-water emulsion including a phospholipid obtained from a marine crustacean.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: November 25, 2014
    Assignee: Stable Solutions LLC
    Inventor: David F. Driscoll
  • Publication number: 20140335061
    Abstract: Disclosed are compositions and methods comprising supplemented oils for improving health, reducing cardiovascular risk factors, or treating certain conditions.
    Type: Application
    Filed: December 7, 2012
    Publication date: November 13, 2014
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, Robert H. Lerman
  • Publication number: 20140322346
    Abstract: The invention discloses a new solvent-free process for obtaining phospholipids and neutral lipids enriched krill oils containing DHA and EPA poly-unsaturated fatty acids and astaxanthin. The process includes cooking fresh krill at high temperature—without agitation and or grinding; decanting the cooked krill for obtaining a partial de-fatted and de-watered solid and a liquid; squeezing the obtained solid to obtain a press liquid and a solid fraction; centrifuging the press liquid to obtain the phospholipids enriched krill oil; centrifuging of the decanter liquid obtained to obtain the neutral lipid enriched krill oil and stickwater.
    Type: Application
    Filed: July 11, 2014
    Publication date: October 30, 2014
    Inventors: Dimitri SCLABOS KATEVAS, Raúl R. TORO GUERRA, Mario CHIONG LAY
  • Publication number: 20140294987
    Abstract: A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.
    Type: Application
    Filed: June 11, 2014
    Publication date: October 2, 2014
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Publication number: 20140271907
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: AMARIN PHARMACEUTICALS IRELAND LIMITED
    Inventor: Joseph S. Zakrzewski
  • Publication number: 20140248369
    Abstract: A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual. The composition includes a perilla seed oil extract, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin and meso-zeaxanthin.
    Type: Application
    Filed: May 13, 2014
    Publication date: September 4, 2014
    Applicant: U.S. NUTRACEUTICALS, LLC d/b/a Valensa International
    Inventors: JOHN A. MINATELLI, W. STEPHEN HILL, RUDI E. MOERCK, UY NGUYEN
  • Patent number: 8821878
    Abstract: The disclosure features methods of making compositions that include a human lipid. The methods can include: obtaining whole human milk; separating the milk into a cream portion and a skim portion; processing the cream portion; and pasteurizing the processed cream portion.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: September 2, 2014
    Assignee: Prolacta Bioscience, Inc.
    Inventors: Elena M. Medo, Scott Eaker
  • Publication number: 20140227204
    Abstract: Skin compositions comprising, hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and related method for protecting, healing and/or soothing the skin comprising: applying an effective amount of a cosmetic preparation selected from the group consisting of hand cream, foot cream, body cream, lip cream, lip gloss, lip stick, gel, balm and lotion to the skin surface; wherein said cosmetic preparation includes a skin composition made of hydrocortisone; allantoin; and a water-based vehicle that is essentially free of petroleum jelly, mineral oil and wax; and said effective amount is enough to protect, heal and/or soothe the skin surface.
    Type: Application
    Filed: February 11, 2013
    Publication date: August 14, 2014
    Inventor: Norman Turkowitz
  • Publication number: 20140178487
    Abstract: The embodiments herein provide camel hump oil based herbal compositions and methods for preparing these compositions for treatment of a plurality of diseases such as dermatological conditions, musculoskeletal conditions and hair conditions. The embodiments herein also provide a method of extraction of camel hump oil from a camel hump and a method of de-odorizing the extracted camel hump. The camel hump-oil based herbal composition comprises camel hump oil, a herbal oil extract, a curing agent and a plurality of additives. The camel hump oil based composition is topically applied.
    Type: Application
    Filed: December 24, 2012
    Publication date: June 26, 2014
    Inventor: Nafiseh Nili
  • Publication number: 20140178488
    Abstract: A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from Euphasia spp., comprising Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids in the form of triacylglycerides and phospholipids. The krill oil includes at least 10% EPA and 5% DHA, of which greater than 50% are in the form of phospholipids and the 1-4000 mg of krill oil per daily dose is delivered.
    Type: Application
    Filed: February 26, 2014
    Publication date: June 26, 2014
    Applicant: U.S. NUTRACEUTICALS, LLC d/b/a Valensa International
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Publication number: 20140170231
    Abstract: An analgesic composition useful for soothing body aches, pains and sores. The analgesic composition can include methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil. Methods for soothing body aches. The methods include administering an analgesic composition topically at a location of a body ache.
    Type: Application
    Filed: December 17, 2013
    Publication date: June 19, 2014
    Applicant: Derjers International
    Inventors: Axel Cooley, Derrick Cooley, John Cooley
  • Publication number: 20140134261
    Abstract: The present invention relates to pharmaceutical compositions comprising ester(s) of capsaicin and at least one other agent selected from salicylates, menthol, boswellic acids, DMSO, methyl sulfonylmethane, NSAIDs, corticosteroids, emu oil, opioid agonists and antagonists, NMDA antagonists, tramadol, hyaluronic acid, ?2? ligands, santalol, santalyl acetate, amyris alcohol, amyris acetate, aloe vera gel and aloe vera juice, for improved therapeutic properties. Further, the present invention relates to pharmaceutical compositions comprising high concentrations of ester(s) of capsaicin. Further, the present invention relates to a method of relieving pain due to various diseases in subjects by administering the pharmaceutical compositions of the invention.
    Type: Application
    Filed: August 21, 2013
    Publication date: May 15, 2014
    Applicant: Trinity Laboratories, Inc.
    Inventors: Chandra U. Singh, David L. Woody, Rao Nulu Jagaveerabhadra
  • Publication number: 20140120172
    Abstract: The present invention relates to an alcoholic injury mitigating agent comprising krill oil as an active ingredient. The krill oil preferably comprises phospholipids in an amount of at least 30% by weight, ?3 polyunsaturated fatty acids in an amount of at least 5% by weight of the total fatty acids, eicosapentaenoic acid in an amount of at least 2% by weight of the total fatty acids, or docosahexaenoic acid in an amount of at least 1% by weight of the total fatty acids.
    Type: Application
    Filed: January 6, 2014
    Publication date: May 1, 2014
    Applicant: NIPPON SUISAN KAISHA, LTD.
    Inventors: Junichiro HATA, Tomoko TSUJI, Kenichi YANAGIMOTO